Meeting the educational needs of women with triple-negative breast cancer (TNBC).

被引:0
|
作者
Swiger, Kathleen Dickerson
Sendecki, Jocelyn A.
Guglielmino, Janine E.
Rugo, Hope S.
Domchek, Susan M.
Anders, Carey K.
Stricker, Carrie Tompkins
Nelson, Hillary C. M.
Hanson, Arin Ahlum
Dinerman, Hayley
Henry, Catherine Creme
机构
[1] Living Breast Canc, Haverford, PA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] Triple Negat Breast Canc Fdn, Norwood, NJ USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e20580
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Copper chaperons as novel targets for therapy in triple-negative breast cancer (TNBC)
    Karginova, O.
    Song, A.
    Wang, J.
    Luo, C.
    Jiang, H.
    He, C.
    Olopade, O. I.
    [J]. CANCER RESEARCH, 2016, 76
  • [32] Alignment of patient-clinician perspectives in triple-negative breast cancer (TNBC).
    Ackbarali, Tariqa
    Goins, Chelsey
    Walker, Stephanie
    Donahue, Sara
    Witt, Jennifer
    Vidal, Gregory A.
    Traina, Tiffany A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Routinely applicable, highly multiplexed triple-negative breast cancer (TNBC) genotyping
    Kotoula, Vassiliki
    Papadopoulou, Kyriaki
    Charalambous, Elpida
    Zagouri, Flora
    Lakis, Sotiris
    Lymperopoulou, Angeliki
    Tsolaki, Eleftheria
    Pentheroudakis, George
    Lilakos, Kostas
    Pectasides, Dimitrios
    Fountzilas, George
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [34] A Phase II study of cabozantinib for metastatic triple-negative breast cancer (TNBC).
    Tolaney, Sara M.
    Ziehr, David R.
    Guo, Hao
    Barry, William Thomas
    Higgins, Michaela Jane
    Isakoff, Steven J.
    Brock, Jane E.
    Ivanova, Elena
    Paweletz, Cloud
    Demeo, Michelle
    Ramaiya, Nikhil H.
    Overmoyer, Beth
    Jain, Rakesh K.
    Duda, Dan G.
    Winer, Eric P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [35] Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
    Chaudhuri, Aiswarya
    Kumar, Dulla Naveen
    Dehari, Deepa
    Singh, Sanjay
    Kumar, Pradeep
    Bolla, Pradeep Kumar
    Kumar, Dinesh
    Agrawal, Ashish Kumar
    [J]. PHARMACEUTICALS, 2022, 15 (05)
  • [36] The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
    Farghadani, Reyhaneh
    Naidu, Rakesh
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
  • [37] Defining triple-negative breast cancer with neuroendocrine differentiation (TNBC-NED)
    Hacking, Sean M.
    Yakirevich, Evgeny
    Wang, Yihong
    [J]. JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2023, 9 (04): : 313 - 321
  • [38] Molecular pathways and therapeutic targets linked to triple-negative breast cancer (TNBC)
    Mustafa, Mohd
    Abbas, Kashif
    Alam, Mudassir
    Ahmad, Waleem
    Moinuddin
    Usmani, Nazura
    Siddiqui, Shahid Ali
    Habib, Safia
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (04) : 895 - 913
  • [39] Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC)
    Kanugo, Abhishek
    Gautam, Rupesh K.
    Kamal, Mohammad Amjad
    [J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (13) : 1581 - 1595
  • [40] Chemokine network between triple-negative breast cancer (TNBC) and non-TNBC cells.
    Gibbs, Carla
    Ignacio, Rosa
    Hyeong, Choi
    Son, Deok-Soo
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 88 - 89